Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Nike
NKE
5
Amazon
AMZN
SG Stock MarketDetailed Quotes
1J5 Hyphens Pharma
- 0.280
- -0.005-1.75%
10min DelayMarket Closed Apr 4 11:06 CST
86.49MMarket Cap8.75P/E (TTM)
0.285High0.280Low134.30KVolume0.285Open0.285Pre Close37.82KTurnover0.30052wk High0.23%Turnover Ratio308.88MShares0.26052wk Low0.032EPS TTM16.28MFloat Cap0.430Historical High8.75P/E (Static)58.13MShs Float0.103Historical Low0.032EPS LYR1.75%Amplitude0.01Dividend TTM1.22P/B100Lot Size3.21%Div YieldTTM
Hyphens Pharma Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | (Q3)Sep 30, 2020 | (Q2)Jun 30, 2020 | (Q1)Mar 31, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 14.55%195.42M | 5.10%170.6M | 28.94%162.32M | 4.06%125.88M | 1.29%120.98M | 27.9M | 2.40%31.44M | 4.13%30.2M | 16.43%31.44M | -1.23%119.44M |
| Cost of revenue | 15.84%125.91M | 9.23%108.69M | 27.90%99.51M | 0.59%77.8M | 0.74%77.34M | 15.72M | 6.37%21.09M | 6.06%20M | 17.17%20.54M | -4.18%76.77M |
| Gross profit | 12.29%69.51M | -1.45%61.9M | 30.63%62.81M | 10.19%48.08M | 2.27%43.64M | 12.18M | -4.84%10.35M | 0.53%10.2M | 15.06%10.9M | 4.57%42.67M |
| Operating expense | 9.91%54.97M | 5.66%50.02M | 19.53%47.34M | 14.47%39.6M | 1.10%34.6M | 8.65M | 3.23%8.86M | 4.81%8.62M | 10.09%8.47M | 6.41%34.22M |
| Staff costs | ---- | ---- | --23.96M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Selling and administrative expenses | 9.91%54.97M | 113.86%50.02M | -41.58%23.39M | 9.20%40.03M | 5.93%36.66M | --10.71M | 3.23%8.86M | 4.81%8.62M | 10.09%8.47M | 7.62%34.61M |
| -Selling and marketing expense | 10.72%39.74M | 113.60%35.89M | -40.82%16.8M | 7.05%28.39M | 6.79%26.52M | --7.83M | 2.18%6.33M | 3.90%6.14M | 20.84%6.24M | 14.27%24.84M |
| -General and administrative expense | 7.84%15.23M | 114.54%14.13M | -43.43%6.58M | 14.81%11.64M | 3.75%10.14M | --2.89M | 5.93%2.54M | 7.15%2.49M | -11.87%2.23M | -6.24%9.77M |
| Research and development costs | ---- | ---- | --242K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Rent and land expenses | ---- | ---- | --242K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other operating expenses | ---- | ---- | 1,050.00%23K | 112.50%2K | 73.33%-16K | ---- | ---- | ---- | ---- | ---60K |
| Total other operating income | ---- | ---- | 18.94%515K | -78.86%433K | 522.49%2.05M | ---- | ---- | ---- | ---- | --329K |
| Operating profit | 22.31%14.54M | -23.19%11.89M | 82.44%15.47M | -6.17%8.48M | 6.98%9.04M | 3.54M | -35.10%1.49M | -17.80%1.58M | 36.45%2.44M | -2.29%8.45M |
| Net non-operating interest income expense | -103.24%-565K | -41.84%-278K | -833.33%-196K | -130.00%-21K | 268.42%70K | 147K | 18.75%-26K | 12.50%-28K | 45.24%-23K | 114.73%19K |
| Non-operating interest income | ---- | ---- | -43.24%42K | -58.89%74K | 14.65%180K | ---- | ---- | ---- | ---- | --157K |
| Non-operating interest expense | 103.24%565K | 16.81%278K | 150.53%238K | -13.64%95K | -20.29%110K | --33K | -18.75%26K | -12.50%28K | -45.24%23K | 6.98%138K |
| Net investment income | -301.97%-923K | 872.34%457K | 149.47%47K | -95K | ||||||
| Gain/Loss on financial instruments designated as cash flow hedges | ||||||||||
| Gain/Loss on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 0 | 14.98%545K | 2,688.24%474K | 17K | 0 | |||||
| Special income /charges | 20.80%-537K | 66.89%-678K | -430.57%-2.05M | -386K | ||||||
| Less:Restructuring and mergern&acquisition | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | ---- | ---- | -25.00%3K | 200.00%4K | -180.00%-4K | ---- | ---- | ---- | ---- | --5K |
| Less:Write off | ---- | ---- | -20.77%534K | -67.15%674K | 438.58%2.05M | ---- | ---- | ---- | ---- | --381K |
| Other non-operating income /expenses | 36.23%-1.01M | -1.59M | -763.83%-406K | 568.21%1.01M | 353.62%175K | |||||
| Income before tax | 22.66%12.96M | -26.07%10.57M | 73.10%14.29M | 16.15%8.26M | -11.01%7.11M | 906K | -52.33%1.05M | 25.49%2.56M | 54.57%2.59M | 14.10%7.99M |
| Income tax | 5.99%2.1M | -31.12%1.99M | 104.40%2.88M | 49.21%1.41M | -35.14%945K | -128K | -49.51%206K | -0.74%402K | 89.02%465K | -8.36%1.46M |
| Net income | 26.52%10.86M | -24.80%8.58M | 66.65%11.41M | 11.08%6.85M | -5.62%6.16M | 1.03M | -52.97%847K | 31.99%2.16M | 48.64%2.12M | 20.70%6.53M |
| Net income continuous operations | 26.52%10.86M | -24.80%8.58M | 66.65%11.41M | 11.08%6.85M | -5.62%6.16M | --1.03M | -52.97%847K | 31.99%2.16M | 48.64%2.12M | 20.70%6.53M |
| Noncontrolling interests | 5,408.33%661K | -79.31%12K | 58K | 0 | ||||||
| Net income attributable to the company | 18.98%10.19M | -24.52%8.57M | 65.80%11.35M | 11.08%6.85M | -5.62%6.16M | 1.03M | -52.97%847K | 31.99%2.16M | 48.64%2.12M | 20.70%6.53M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 18.98%10.19M | -24.52%8.57M | 65.80%11.35M | 11.08%6.85M | -5.62%6.16M | 1.03M | -52.97%847K | 31.99%2.16M | 48.64%2.12M | 20.70%6.53M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 19.13%0.033 | -24.73%0.0277 | 62.11%0.0368 | 10.73%0.0227 | -5.53%0.0205 | 0.0034 | -53.33%0.0028 | 33.33%0.0072 | 47.92%0.0071 | 11.28%0.0217 |
| Diluted earnings per share | 16.97%0.0324 | -24.32%0.0277 | 61.23%0.0366 | 10.73%0.0227 | -5.53%0.0205 | 0.0034 | -53.33%0.0028 | 33.33%0.0072 | 47.92%0.0071 | 11.28%0.0217 |
| Dividend per share | -22.52%0.0086 | 65.67%0.0111 | 8.06%0.0067 | -38.00%0.0062 | 81.82%0.01 | 0 | 0 | 81.82%0.01 | 0 | 0.0055 |
| Currency Unit | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD |